European Archives - Page 533 of 1232 - European Medical Journal

Updates on CAR-NK Cells

This presentation offers insight into chimeric antigen receptor-transduced (CAR) natural killer (NK) cells, providing an update on the involvement of these cells in a host of topics, from stem cell transplantation to cancer.

An Update on Hypertension Management

This webinar gives an update on hypertension management. and it explores the extent of the burden of hypertension, the consequences it can have, and more.

Changing Perceptions in Diabetes

Jonathan is joined by Noel Morgan to discuss his research in diabetes, areas of research that excite him, and beliefs surrounding diabetes.

Interview: Emmanouil Brilakis

Director of the Center for Complex Coronary Interventions, Minneapolis Heart Institute, Minnesota, USA…

Diagnostic pathways for Myocardial infarction: Use in Clinical Practice and Areas for Improvement

This webinar explores myocardial infarction (MI) diagnostic pathways. Our moderator, Sue Saville, will be joined by expert speakers in the…

Risks and Safety in Paediatric Radiology

In a highly engaging session at the European Congress of Radiology (ECR)in Vienna, Austria, which took place 1st–5th March 2023 and was chaired by Hans-Joachim Mentzel, experts came together to discuss risks and safety measures, including different radiology practices in children.

Oral Corticosteroids for Patients with Eosinophilic Diseases: An Expert Panel View on Use, Overuse, and Strategies to Reduce Use

Severe asthma (SA), chronic rhinosinusitis with nasal polyps (CRSwNP), and eosinophilic granulomatosis with polyangiitis (EGPA) are three conditions driven by IL-5 and eosinophilic inflammation. As these conditions have high use of healthcare services, as well as lifestyle and psychological burdens, well-tolerated treatment to achieve optimal control is key.

EMJ 8.1 2023

We are excited to share our first 2023 issue of EMJ, which includes content across medical disciplines, with a mini-focus on paediatric healthcare.

Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease

Setting the scene, Bakris defined CKD as a reduction in kidney function (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2), alongside the presence of albuminuria (≥30 mg/day) as an indication of kidney damage.

The Role of Granulocyte-Colony Stimulating Factor Biosimilars for Supportive Cancer Care: A Year in Review

Chemotherapy-induced neutropenia is a frequent, severe, adverse haematological complication of myelosuppressive and immunosuppressive cytotoxic chemotherapy treatment.